SLAS and ELRIG are pleased to sponsor an educational networking event at the new Novartis Pavillon science hub.
In the last 20 years, targeted protein degradation (TPD) has evolved from a basic scientific observation, involved in the control of hormone signaling in plants as well as virus survival, to a point where compounds directing TPD are in the clinic for a number of disease indications.
On June 7, Pavillon, the new science hub on the Novartis Basel Campus will open its doors to host a mini-symposium on the subject of TPD. Located in Basel, one of the pharmaceutical capitals of Europe, this event aims to present a series of vignettes describing efforts from discovery to the development of novel compounds directing TPD.
Attendees may participate in the meeting live or virtually from 15:00 - 17:00 CEST. This is a great opportunity to network in the informal and stimulating environment of the new Pavillon!